Regeneron (United States), 2024. Regeneron to Showcase Progress in Advancing Novel Investigational Treatment Approaches for a Broad Range of Solid Tumors and Blood Cancers at Asco, Regeneron (United States).
United States of America.
Retrieved from https://coilink.org/20.500.12592/20o8oyp on 15 Nov 2024. COI: 20.500.12592/20o8oyp.